Edwin D. Kilbourne

Edwin D. Kilbourne's AcademicInfluence.com Rankings

Edwin D. Kilbourne

Philosophy

#3668

World Rank

#5882

Historical Rank

#1143

USA Rank

Logic

#1318

World Rank

#2038

Historical Rank

#404

USA Rank

philosophy Degrees

Download Badge

Philosophy

Edwin D. Kilbourne's Degrees

Doctorate Medicine Columbia University
Bachelors Chemistry Columbia University

Why Is Edwin D. Kilbourne Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Edwin Dennis Kilbourne was an American research scientist. Born in Buffalo, New York, he received his AB and MD degrees from Cornell University. After completion of service in the Medical Corps of the Army of the United States at the end of World War II, he trained in virus research at The Rockefeller Institute. Subsequently, he has taught successively on the faculties of four medical schools: Tulane, Cornell, Mount Sinai , and New York Medical College. .

(See a Problem?)

Edwin D. Kilbourne's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Influenza Pandemics of the 20th Century (2006) (1062)
Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. (1959) (461)
Future influenza vaccines and the use of genetic recombinants. (1969) (393)
Protective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice (1968) (261)
Induction of Partial Specific Heterotypic Immunity in Mice by a Single Infection with Influenza A Virus (1965) (257)
Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase (1968) (256)
Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection (1989) (224)
The Influenza viruses and influenza (1975) (220)
Induction of partial immunity to influenza by a neuraminidase-specific vaccine. (1974) (209)
Identification in a recombinant influenza virus of structural proteins derived from both parents. (1966) (181)
Activation of latent herpes simplex by trigeminal sensory-root section. (1952) (171)
Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. (1990) (143)
Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. (1969) (136)
Gene composition of high-yielding influenza vaccine strains obtained by recombination. (1980) (133)
Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8. (1960) (132)
Influenza in Man (1987) (131)
Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. (1987) (129)
Airborne Transmission of Influenza Virus Infection in Mice (1962) (123)
The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone. (1956) (122)
Influenza Pandemics of the 20 th Century (2005) (121)
Isolation and Preliminary Characterization of Temperature-Sensitive Mutants of Influenza Virus (1972) (118)
The influence of quantitated post-weaning undernutrition on coxsackievirus B3 infection of adult mice. I. Viral persistence and increased severity of lesions. (1970) (112)
The total influenza vaccine failure of 1947 revisited: Major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic (2002) (109)
Inhibition by Cortisone of the Synthesis and Action of Interferon (1961) (106)
RNAs of influenza A, B, and C viruses (1976) (104)
Reactions of antibodies with surface antigens of influenza virus. (1968) (103)
Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. (1971) (102)
Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. (1998) (98)
Lethal Infection with Coxsackie Virus of Adult Mice Given Cortisone (1951) (91)
Studies on influenza in the pandemic of 1957-1958. I. An epidemiologic, clinical and serologic investigation of an intrahospital epidemic, with a note on vaccination efficacy. (1959) (89)
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans. (1995) (88)
Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice. (1993) (88)
Studies on influenza in the pandemic of 1957-1958. III. Isolation of influenza A (Asian strain) viruses from influenza patients with pulmonary complications; details of virus isolation and characterization of isolates, with quantitative comparison of isolation methods. (1959) (85)
Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition (1993) (79)
Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication. (1983) (78)
Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans. (1976) (77)
Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults (1996) (76)
Reduction in Plaque Size and Reduction in Plaque Number as Differing Indices of Influenza Virus-Antibody Reactions (1966) (75)
Inhibition of Influenza Virus Multiplication with a Glucose Antimetabolite (2-deoxy-D-glucose) (1959) (73)
GENETIC STUDIES OF INFLUENZA VIRUSES. II. PLAQUE FORMATION BY INFLUENZA VIRUSES IN A CLONE OF A VARIANT HUMAN HETEROPLOID CELL LINE. (1965) (73)
Cranial arteritis; a critical evaluation of the syndrome of temporal arteritis with report of a case. (1946) (70)
Influenza pandemics in perspective. (1977) (69)
Protection of mice with recombinant influenza virus neuraminidase. (2004) (67)
THE INFLUENCE OF INFLUENZA VIRUS INFECTION ON EXOGENOUS STAPHYLOCOCCAL AND ENDOGENOUS MURINE BACTERIAL INFECTION OF THE BRONCHOPULMONARY TISSUES OF MICE (1961) (63)
CHANGING VIRAL SUSCEPTIBILITY OF A HUMAN CELL LINE IN CONTINUOUS CULTIVATION (1961) (63)
Developmental Sequence and Intracellular Sites of Synthesis of Three Structural Protein Antigens of Influenza A2 Virus (1970) (62)
A2 (N2) Neuraminidase of the X-7 Influenza Virus Recombinant: Determination of Molecular Size and Subunit Composition of the Active Unit (1972) (60)
Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience. (1987) (58)
Influenza Virus Polypeptides and Antigens--Summary of Influenza Workshop I (1972) (57)
Recombination of Influenza A Viruses of Human and Animal Origin (1968) (57)
The molecular epidemiology of influenza. (1973) (56)
Genetic dimorphism in influenza viruses: characterization of stably associated hemagglutinin mutants differing in antigenicity and biological properties. (1978) (55)
Studies of herpes simplex virus in newborn mice. (1951) (54)
Epidemiology of Influenza—Summary of Influenza Workshop IV (1973) (53)
Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees. (1971) (52)
Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. (1987) (51)
EXPERIMENTAL TRANSMISSION OF INFLUENZA VIRUS INFECTION IN MICE (1963) (51)
Nonlinkage of Neurovirulence Exclusively to Viral Hemagglutinin or Neuraminidase in Genetic Recombinants of A/NWS (H0N1) Influenza Virus (1973) (50)
Genetic Recombination for Antigenic Markers of Antigenically Different Strains of Influenza B Virus (1974) (47)
Applications of a synthetic neuraminidase substrate. (1973) (44)
Primary herpes simplex virus infection of the adult, with a note on the relation of herpes simplex virus to recurrent aphthous stomatitis. (1951) (44)
Increased Virus in Eggs Injected with Cortisone (1951) (43)
Induced Reactivation of Herpes Simplex Virus in Healed Rabbit Corneal Lesions.∗ (1961) (43)
Influenza pandemics: can we prepare for the unpredictable? (2004) (43)
Penicillin treatment of streptococcal pharyngitis. (1948) (42)
Antibody response in man to influenza virus neuraminidase following influenza (1968) (42)
The influence of cortisone on experimental viral infection. I. Prolongation of survival time and suppression of inflammation in chick embryos infected with influenza B virus. (1955) (42)
GENETIC STUDIES OF INFLUENZA VIRUSES (1960) (41)
THE INFLUENCE OF CORTISONE ON EXPERIMENTAL VIRAL INFECTION (1957) (40)
Complementation of recombinant baculoviruses by coinfection with wild-type virus facilitates production in insect larvae of antigenic proteins of hepatitis B virus and influenza virus. (1989) (39)
Chromatographic isolation of the hemagglutinin polypeptides from influenza virus vaccine and determination of their amino-terminal sequences. (1976) (38)
Perspectives on pandemics: a research agenda. (1997) (38)
AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM FUNICULOSUM (1966) (38)
Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice. (1987) (37)
Influenza immunity: new insights from old studies. (2006) (36)
Genetic composition of a high-yielding influenza A virus recombinant: a vaccine strain against "Swine" influenza. (1976) (35)
Immunization with Asian-strain influenza vaccine: equivalence of the subcutaneous and intradermal routes. (1958) (35)
Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants. (1995) (34)
EXPERIMENTAL TRANSMISSION OF INFLUENZA VIRUS INFECTION IN MICE (1963) (34)
Differences in the biological phenotype of low-yielding (L) and high-yielding (H) variants of swine influenza virus A/NJ/11/76 are associated with their different receptor-binding activity. (1998) (33)
Influenza A prime: a clinical study of an epidemic caused by a new strain of virus. (1950) (33)
Temperature-sensitive mutants of influenza virus: a mutation in the hemagglutinin gene. (1976) (33)
Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. (1996) (32)
Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition. (1994) (31)
Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections. (1990) (30)
Demonstration of antibodies to both hemagglutinin and neuraminidase antigens of H3N2 influenza A virus in domestic dogs. (1975) (29)
Isolation of immunogenic neuraminidases of human influenza viruses by a combination of genetic and biochemical procedures (1984) (27)
The antigenic relationship of the neuraminidase of Hong Kong virus to that of other human strains of influenza A virus. (1969) (27)
Differing Susceptibility of Adolescent and Adult Mice to Non-lethal Infection with Coxsackievirus B3 1 (1971) (26)
Preparation and characterization of a purified influenza virus neuraminidase vaccine. (1995) (25)
THE INFLUENCE OF CORTISONE ON EXPERIMENTAL VIRAL INFECTION (1955) (25)
Opinion Influenza As a Problem in Immunology (1978) (24)
The coxsackie viruses and human disease. (1952) (24)
Hemagglutinin polymorphism as the basis for low- and high-yield phenotypes of swine influenza virus. (1988) (23)
Immunization with 1976 swine H1N1‐ or 2009 pandemic H1N1‐inactivated vaccines protects mice from a lethal 1918 influenza infection (2011) (22)
In pursuit of influenza: Fort Monmouth to Valhalla (and back). (1997) (22)
THE INFLUENCE OF CORTISONE ON EXPERIMENTAL VIRAL INFECTION (1957) (22)
Coxsackie viruses and virus-like diseases of the adult; a three-year study in a contagious disease hospital. (1956) (22)
Identification of PR8 M1 protein in influenza virus high-yield reassortants by M1-specific monoclonal antibodies. (1989) (21)
From the National Institutes of Health (1973) (20)
In vitro Effects of Cortisone on Multiplication of Influenza B Virus.∗ (1953) (19)
Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. (1994) (19)
New viruses and new disease: mutation, evolution and ecology. (1991) (19)
New viral diseases. A real and potential problem without boundaries. (1990) (18)
Detection of influenza virus neuraminidase-specific antibodies by an enzyme-linked immunosorbent assay (1982) (17)
Hemagglutinin mutants of swine influenza virus differing in replication characteristics in their natural host (1979) (17)
Influenza: viral determinants of the pathogenicity and epidemicity of an invariant disease of variable occurrence. (1980) (17)
The Epidemiology of Influenza (1987) (17)
Endemic influenza. II. The nature of the disease in the post-pandemic period. (1962) (16)
Inhibition of Viral Neuraminidase As a New Approach to the Prevention of Influenza (1975) (16)
Comparative amino acid analysis of influenza A viral proteins. (1980) (16)
Influence of Cortisone on Experimental Viral Infection. II. Effects on Antibody Formation and Acquired Immunity.∗ (1955) (16)
THE COMPARATIVE EFFECTS OF CONTINUOUS AND INTERMITTENT PENICILLIN THERAPY ON THE FORMATION OF ANTISTREPTOLYSIN IN HEMOLYTIC STREPTOCOCCAL PHARYNGITIS. (1948) (15)
An explanation of the interpandemic antigenic mutability of influenza viruses. (1973) (15)
Concurrent infection with influenza A and B viruses in a single epidemic of influenza. (1951) (15)
Induction of Viral Interference in Mice by Aerosols of Inactivated Influenza Virus.∗ (1963) (15)
Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants. (1993) (15)
THE INFLUENCE OF CORTISONE ON EXPERIMENTAL VIRAL INFECTION (1957) (15)
A herpes simplex skin test diagnostic antigen of low protein content from cell culture fluid. (1961) (15)
Influenza as a problem in immunology. (1978) (14)
Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals. (1971) (13)
What are the prospects for a universal influenza vaccine? (1999) (12)
Monoclonal antibodies to the hemagglutinin Sa antigenic site of a/pr/8/34 influenza virus distinguish biologic mutants of swine influenza virus. (1983) (12)
Comparison of intranasal and aerosol infection of mice in assessment of immunity to influenza virus infection. (1991) (12)
Detection of antibodies to influenza virus M protein by an enzyme-linked immunosorbent assay (1982) (12)
Serial Multiplication of an Influenza Virus (NWS) in Certain Human Diploid Cell Strains.∗ (1964) (12)
Endemic influenza. I. Serologic evidence of continuing and subclinical infection in disparate populations in the post-pandemic period. (1962) (12)
Programmed antigenic stimulation: kinetics of the immune response to challenge infections of mice primed with influenza inactivated whole virus or neuraminidase vaccine. (1991) (11)
Hemolytic Activity of Diethylstilbestrol and Some Steroid Hormones.∗ (1954) (11)
THE INFLUENCE OF CORTISONE ON EXPERIMENTAL VIRAL INFECTION (1957) (11)
Plagues and pandemics: past, present, and future (2008) (11)
Genetic studies of influenza viruses. 3. Production of plaque-type recombinants with A0 and A1 strains. (1966) (10)
REACTIVATION OF NON-INFECTIVE VIRUS IN A CORTISONE-INJECTED HOST (1955) (10)
Evolution to predominance of swine influenza virus hemagglutinin mutants of predictable phenotype during single infections of the natural host. (1988) (10)
Influenza 1970: unquestioned answers and unanswered questions. (1970) (10)
Segmented Genome Viruses and the Evolutionary Potential of Asymmetrical Sex (2015) (10)
Mutation in the hemagglutinin of A/N-WS/33 influenza virus recombinants influencing sensitivity to trypsin and antigenic reactivity. (1980) (10)
The Politics of Emerging and Resurgent Infectious Diseases (2001) (9)
The induction of broadened (multitypic) immunity with doubly antigenic influenza virus recombinants. (1965) (9)
A Chemical Method for the Detection of Virus Infection of the Chick Embryo (1949) (9)
The emergence of "emerging diseases": a lesson in holistic epidemiology. (1996) (9)
Influenza vaccine strain selection: equivalence of two antigenically distinct haemagglutinin variants of 1989 H3N2 influenza A virus in protection of mice. (1992) (8)
Rapid confirmation by RFLP of transfer to vaccine candidate reassortment viruses of the principal 'high yield' gene of influenza A viruses. (2002) (8)
Humor in science. (1996) (8)
The syndrome of fatal influenza virus pneumonia. (1958) (7)
Programmed Antigenic Stimulation — A New Approach to Influenza Vaccination (1991) (7)
Cytopathogenesis and Cytopathology of Influenza Virus Infection of Cells in Culture (1987) (7)
Preventive medicine and public health. (1952) (6)
The Control of Influenza (1987) (6)
Heredofamilial cerebellar ataxia with spastic paralysis and spinal muscular atrophy; report of two cases of an unusual syndrome. (1949) (6)
Influenza Virus Genetics, Viral Adaptation, and Evolution (1987) (6)
Influenza Vaccines [and Discussion] (1980) (6)
Human ecology and public health. (1970) (6)
Comparison Influenza B Virus Strains from the 1950 Epidemic with Strains from Earlier Epidemics (1950) (6)
THE INFLUENCE OF CORTISONE ON EXPERIMENTAL VIRAL INFECTION (1966) (5)
A Race with Evolution: A History of Influenza Vaccines (2011) (5)
Taxonomy and Comparative Virology of the Influenza Viruses (1987) (5)
Effect of Hydrocortisone on Growth and Detachment of Human Heteroploid Cells in Maintenance Media.∗ (1967) (4)
Molecular epidemiology--influenza as archetype. (1979) (4)
History of Influenza (1987) (4)
The leukopenia of virus infection—Relation to the concentration of virus and the viral lesion (1955) (4)
Genetics, Replication, and Inhibition of Replication of Influenza Virus—Summary of Influenza Workshop VII (1975) (4)
Diverse manifestations of infection with a strain of Coxsackie virus. (1950) (4)
Replication of Influenza Viruses (1987) (3)
The inaccessibility of genetically active but noninfective influenza virus to the intracellular action of ribonuclease. (1960) (3)
Purified Influenza VirusHemagglutinin andNeuraminidase Are Equivalent inStimulation ofAntibody Response butInduce Contrasting TypesofImmunity toInfection (1989) (3)
The emergence of the physician-basic scientist in America. (1986) (3)
Influenza Research in the Soviet Union—1974 (1974) (3)
Structural polypeptides of antigenically distinct strains of influenza B virus (2005) (3)
Isolation andPreliminary Characterization of Temperature-Sensitive Mutants ofInfluenza Virus (1972) (3)
Viral Structure and Composition (1987) (3)
The Hot Zone: The Coming Plague (1995) (3)
Immunologic Methodology in Influenza Diagnosis and Research—Summary of Inftuenza Workshop II (1972) (3)
A revised system of influenza virus nomenclature. A report of the WHO study group on classification. (1972) (3)
Effects of compounds A, E and F on experimental viral infection (1953) (2)
The Evolution of Influenza Viral Genetics— A Perspective (1983) (2)
Minor Disease in Ten " Healthy " Adults. An Intensive, Day-by-Day, Clinical and Virologie Study. (1960) (2)
Influenza--the cryptic killer. (1961) (2)
Commentary on fatalities in the 1918-1919 influenza pandemic. (2009) (2)
Pandora's box and the history of the respiratory viruses: a case study of serendipity in research. (1992) (2)
Interferon Production in Neonatally Thymectomized Mice.∗ (1967) (2)
Mouse-egg neutralization; neutralization in the mouse of influenza viruses not adapted to the mouse. (1951) (2)
Influenza mortality and morbidity. (1978) (2)
Intradermal vaccination against influenza. (2005) (2)
National immunization for pandemic influenza. (1976) (2)
Pulmonary Manifestations of Gasoline Intoxication. A Review with Report of a Case. (1950) (2)
Influenza: the vaccines. (1971) (1)
PLEIOTROPIC EFFECTS OF A SINGLE AMINO ACID CHANGE ON ANTIGENICITY AND BIOLOGIC FUNCTION OF SWINE INFLUENZA VIRUS HEMAGGLUTININ MUTANTS (1984) (1)
Immunization for A2 (Asian) influenza in 1962. (1963) (1)
Rational antibiotic therapy. (1953) (1)
The Laboratory Diagnosis of Influenza (1987) (1)
The transmission of epidemic influenza: R. Edgar Hope-Simpson. Plenum Press, New York, 1992. ISBN-0-306-44073-3. $45.00 (1993) (1)
Interferon production in neonatally thymectomized mice. (1968) (1)
Recent contributions of molecular biology to the clinical virology of myxoviruses. (1980) (1)
I. VIRAL MORPHOLOGY AND GROWTH CAPACITY AS EXCHANGEABLE GENETIC TRAITS. RAPID IN OVO ADAPTATION OP EARLY PASSAGE ASIAN STRAIN ISOLATES BY COMBINATION WITH PR8 (1959) (1)
Respiratory disease outbreaks. Extrapolation of experimental animal models to human populations. (1967) (1)
Viruses Affecting Man and Animals (1972) (1)
Therapy of infections. (1958) (1)
CHAPTER 17 – Pandemic Influenza: Molecular and Ecological Determinants (1978) (1)
Virus Paleontology, Disease, and Evolution: an introduction (2004) (1)
AMEBIC ABSCESS OF THE LIVER-ITS TREATMENT. (1930) (0)
A Rondelay (Without Cadenza) By The Virion Of Influenza (2008) (0)
Virus Research (1949) (0)
Hemagglutinin polymorphism asthebasis forlow-andhigh-yield phenotypes ofswineinfluenza virus (1988) (0)
Discussion (1966) (0)
Pulmonary manifestions of gasoline intoxication. (1950) (0)
AD O PURIFICATION (2016) (0)
New Approaches to the Prevention of Influenza (2009) (0)
EFFECTS OF COMPOUNDSA,E AND F ON EXPISRI- (1953) (0)
Purification of Influenza Virus Polypeptide Antigens and Studies of their Immunogenicity and Toxicity (1975) (0)
Prospects for Improved Immunization Against Influenza (1986) (0)
improved viral vaccines. (1996) (0)
Flu hybrids: a cause of vaccine obsolescence? (1966) (0)
Author index (1975) (0)
Presentation of the Academy Medal to George K. Hirst, M.D. (1975) (0)
Dissociation ofInfluenza VirusHemagglutinin and Neuraminidase Eliminates TheirIntravirionic Antigenic Competition (1993) (0)
Memoranda IMemorandums Cell culture asasubstrate fortheproduction of influenza vaccines: MemorandumfromaWHO meeting* (1995) (0)
Multiple Sclerosis -- 1956-69 -- Other Diseases Researched, Miscellaneous -- letter, 1958-02-25 (1958) (0)
Book reviews (2005) (0)
HUMAN ADAPTATION TO INFLUENZA VIRAL EVOLUTION (1981) (0)
The Genetic Dissection of Viral Virulence (1984) (0)
Science, Reviewer -- 1957-68 -- Professional Affiliations and Memberships, Correspondence (Journals) -- text, 1957-08-05 (1957) (0)
IV. NEGATION OF INTERFERENCE AS THE MECHANISM BY WHICH CORTISONE INDUCES INCREASED VIRUS YIELDS BY EDWIN D. KILBOURNE, M.D (1957) (0)
Book ReviewThe Diffusion of Influenza: Patterns and paradigms (1987) (0)
Mouse-Egg Neutralization (1951) (0)
Developmental Sequence andIntracellular Sites ofSynthesis ofThreeStructural Protein Antigens ofInfluenza A2Virus (1970) (0)
RECOMBINATION AND TRANSMISSION STUDIES WITH INFLUENZA VIRUS (1965) (0)
Minor Disease in Ten “Healthy” Adults1, 2 (2015) (0)
Planning forinfluenza epidemics (1976) (0)
It's All Happening at the Zoo (1984) (0)
Ode to Edith (1989) (0)
T H E INFLUENCE OF CORTISONE ON E X P E R I M E N T A L VIRAL INFECTION VIII; SIYI?PRESSION BY CORTISONE OF INTERFERON FORMATION IN MICE INJECTED WITH NEWCASTLE DISEASE VIRUS* (2003) (0)
Biodiversity and Human Health (1998) (0)
Presentation of the Academy Medal to Thomas C. Chalmers, M.D. (1987) (0)
Died on the Fourth of July (1984) (0)
Pandora's box: new viruses and respiratory tract disease. (1958) (0)
Opinion (1978) (0)
Endemic Influenza1,2 (2015) (0)

This paper list is powered by the following services:

Other Resources About Edwin D. Kilbourne

en.wikipedia.org

What Schools Are Affiliated With Edwin D. Kilbourne?

Edwin D. Kilbourne is affiliated with the following schools:

Edwin D. Kilbourne's Academic­Influence.com Rankings